These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
162 related items for PubMed ID: 27054515
1. Changing Azole Resistance: A Secondary Analysis of the MUTT I Randomized Clinical Trial. Prajna NV, Lalitha P, Rajaraman R, Krishnan T, Raghavan A, Srinivasan M, O'Brien KS, Zegans M, McLeod SD, Acharya NR, Keenan JD, Lietman TM, Rose-Nussbaumer J, Mycotic Ulcer Treatment Trial Group. JAMA Ophthalmol; 2016 Jun 01; 134(6):693-6. PubMed ID: 27054515 [Abstract] [Full Text] [Related]
2. Vision-Related Quality-of-Life Outcomes in the Mycotic Ulcer Treatment Trial I: A Randomized Clinical Trial. Rose-Nussbaumer J, Prajna NV, Krishnan KT, Mascarenhas J, Rajaraman R, Srinivasan M, Raghavan A, Oldenburg CE, O'Brien KS, Ray KJ, McLeod SD, Porco TC, Lietman TM, Acharya NR, Keenan JD, Mycotic Ulcer Treatment Trial I Group. JAMA Ophthalmol; 2015 Jun 01; 133(6):642-6. PubMed ID: 25764482 [Abstract] [Full Text] [Related]
3. Patterns of Antifungal Resistance in Adult Patients With Fungal Keratitis in South India: A Post Hoc Analysis of 3 Randomized Clinical Trials. Prajna NV, Lalitha P, Krishnan T, Rajaraman R, Radnakrishnan N, Srinivasan M, Devi L, Das M, Liu Z, Zegans ME, Acharya NR, Porco TC, Lietman TM, Rose-Nussbaumer J. JAMA Ophthalmol; 2022 Feb 01; 140(2):179-184. PubMed ID: 35024776 [Abstract] [Full Text] [Related]
4. Adjunctive Oral Voriconazole Treatment of Fusarium Keratitis: A Secondary Analysis From the Mycotic Ulcer Treatment Trial II. Prajna NV, Krishnan T, Rajaraman R, Patel S, Shah R, Srinivasan M, Devi L, Das M, Ray KJ, O'Brien KS, Oldenburg CE, McLeod SD, Zegans ME, Acharya NR, Lietman TM, Rose-Nussbaumer J, Mycotic Ulcer Treatment Trial Group. JAMA Ophthalmol; 2017 Jun 01; 135(6):520-525. PubMed ID: 28426856 [Abstract] [Full Text] [Related]
10. The Prognostic Value of Persistent Culture Positivity in Fungal Keratitis in the Mycotic Antimicrobial Localized Injection Trial. Pickel J, Narayana S, Krishnan T, Ramakrishnan S, Samantaray PP, Porco TC, Redd T, Lietman TM, Rose-Nussbaumer J. Am J Ophthalmol; 2020 Jul 01; 215():1-7. PubMed ID: 32171765 [Abstract] [Full Text] [Related]
11. Organism, minimum inhibitory concentration, and outcome in a fungal corneal ulcer clinical trial. Lalitha P, Prajna NV, Oldenburg CE, Srinivasan M, Krishnan T, Mascarenhas J, Vaitilingam CM, McLeod SD, Zegans ME, Porco TC, Acharya NR, Lietman TM. Cornea; 2012 Jun 01; 31(6):662-7. PubMed ID: 22333662 [Abstract] [Full Text] [Related]
12. Comparison of natamycin and voriconazole for the treatment of fungal keratitis. Prajna NV, Mascarenhas J, Krishnan T, Reddy PR, Prajna L, Srinivasan M, Vaitilingam CM, Hong KC, Lee SM, McLeod SD, Zegans ME, Porco TC, Lietman TM, Acharya NR. Arch Ophthalmol; 2010 Jun 01; 128(6):672-8. PubMed ID: 20547942 [Abstract] [Full Text] [Related]
13. Voriconazole versus natamycin as primary treatment in fungal corneal ulcers. Arora R, Gupta D, Goyal J, Kaur R. Clin Exp Ophthalmol; 2011 Jul 01; 39(5):434-40. PubMed ID: 21105974 [Abstract] [Full Text] [Related]
14. The Utility of Repeat Culture in Fungal Corneal Ulcer Management: A Secondary Analysis of the MUTT-I Randomized Clinical Trial. Ray KJ, Lalitha P, Prajna NV, Rajaraman R, Krishnan T, Srinivasan M, Ryg P, McLeod S, Acharya NR, Lietman TM, Rose-Nussbaumer J, Mycotic Ulcer Treatment Trial Group. Am J Ophthalmol; 2017 Jun 01; 178():157-162. PubMed ID: 28385473 [Abstract] [Full Text] [Related]
15. Necessity to identify the causative agent for appropriate treatment in fungal corneal ulcer: an in vitro study. Gupta MK, Chandra A, Prakash P, Tilak R. J Mycol Med; 2018 Mar 01; 28(1):201-205. PubMed ID: 29398639 [Abstract] [Full Text] [Related]
16. Risk factors for low vision related functioning in the Mycotic Ulcer Treatment Trial: a randomised trial comparing natamycin with voriconazole. Rose-Nussbaumer J, Prajna NV, Krishnan T, Mascarenhas J, Rajaraman R, Srinivasan M, Raghavan A, Oldenburg CE, O'Brien KS, Ray KJ, Porco TC, McLeod SD, Acharya NR, Keenan JD, Lietman TM, Mycotic Ulcer Treatment Trial Group. Br J Ophthalmol; 2016 Jul 01; 100(7):929-932. PubMed ID: 26531051 [Abstract] [Full Text] [Related]
17. In vitro susceptibility of filamentous fungi from mycotic keratitis to azole drugs. Shobana CS, Mythili A, Homa M, Galgóczy L, Priya R, Babu Singh YR, Panneerselvam K, Vágvölgyi C, Kredics L, Narendran V, Manikandan P. J Mycol Med; 2015 Mar 01; 25(1):44-9. PubMed ID: 25541256 [Abstract] [Full Text] [Related]
18. Effect of pretreatment with antifungal agents on clinical outcomes in fungal keratitis. Sun CQ, Prajna NV, Krishnan T, Rajaraman R, Srinivasan M, Raghavan A, O'Brien KS, McLeod SD, Acharya NR, Rose-Nussbaumer J, Mycotic Ulcer Treatment Trial Group. Clin Exp Ophthalmol; 2016 Dec 01; 44(9):763-767. PubMed ID: 27329780 [Abstract] [Full Text] [Related]
19. Mycotic Antimicrobial Localized Injection: A Randomized Clinical Trial Evaluating Intrastromal Injection of Voriconazole. Narayana S, Krishnan T, Ramakrishnan S, Samantaray PP, Austin A, Pickel J, Porco T, Lietman T, Rose-Nussbaumer J. Ophthalmology; 2019 Aug 01; 126(8):1084-1089. PubMed ID: 30904540 [Abstract] [Full Text] [Related]
20. Therapeutic Penetrating Keratoplasty Button Cultures in The Mycotic Ulcer Treatment Trial II: A Randomized Trial Comparing Oral Voriconazole Versus Placebo. Cho J, Prajna NV, Lalitha P, Rajaraman R, Krishnan T, Lin YB, Ray KJ, Lietman TM, Rose-Nussbaumer J, Mycotic Ulcer Treatment Trial Group. Am J Ophthalmol; 2018 Aug 01; 192():142-145. PubMed ID: 29758184 [Abstract] [Full Text] [Related] Page: [Next] [New Search]